Common Names: balloonvine, love in a puff
This research evaluated two types of nanoemulsions, CHE-NE-A and CHE-NE-B, for their potential as drug carriers. CHE-NE-A showed better drug release, antioxidant activity, antibacterial activity, and antifungal activity compared to CHE-NE-B. It may be considered as a useful drug carrier.
Researchers have identified four potential inhibitors of the SARS-CoV-2 Main protease, an important protein for viral replication. The ligands were evaluated based on docking scores, predicted binding energies, and in silico ADME analysis. One of the top ligands is a natural product from Andrographis nallamalayana, which exhibited a high binding energy close to clinical candidates Boceprevir and GC376. The lead molecules also showed stable interactions with the viral protease during replicated MD simulations. These findings provide a promising opportunity for developing drug candidates to combat COVID-19.